Cainiao partners Ethiopian Airlines to move temperature-controlled vaccines
ALIBABA's logistics arm Cainiao has partnered Ethiopian Airlines to launch a special cold chain air freight for the transportation of temperature-controlled medicines from Shenzhen Airport, China's first medical cross-border cold chain facility
10 December 2020 - 19:00
The logistics company said in a statement that temperature-controlled medicines will be distributed twice a week from Shenzhen to Africa, and to the rest of the world via Dubai and Addis Ababa.
'This is China's first cross-border medical cold chain route to be operated regularly and is certified to transport temperature-controlled medicines including Covid-19 vaccines,' the statement said.
As the fourth airport in Mainland China that obtained International Air Transport Association (IATA)'s Centre of Excellence for Independent Validators (CEIV) certification for pharmaceutical logistics, Shenzhen Airport is also well-equipped to handle biotechnology products. The cargo terminal in Ethiopia is outfitted with compartmentalised cold storage facilities. It occupies an area of 54,000 square metres, with dedicated cool dollies and pharma team, as well as real-time temperature monitoring system to ensure a safe and seamless cold chain logistics for handling temperature sensitive healthcare products.
'Cainiao's global logistics network spans over 200 countries and regions, providing end-to-end integrated logistics services, including digital customs clearance capabilities,' said James Zhao, general manager of Cainiao International Supply Chain. 'The launch of the cold chain air freight has further bolstered our global logistics capabilities, and allows us to offer a one-stop solution for the global distribution of medical products such as the Covid-19 vaccines.'
Tewolde GebreMariam, Ethiopian Group CEO said 'Ethiopian Airlines will repeat its remarkable and globally recognized success in leading the fast delivery of PPEs few months ago with similar delivery speed, professional handling and maintaining the cold chain during the forthcoming global distribution of the Covid-19 vaccine. In anticipation of the Covid-19 vaccine release, we will be at the forefront to further discharge our responsibility in the distribution of the vaccine across the globe.'
This news 2075 hits received.